Telomere/Tetrapeptide Research
Dragon Pharma Peptide Product
Dragon Pharma Epitalon is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic tetrapeptide Ephitalon Acetate at a labeled strength of 50 mg. Product specifications, a batch-specific lab report, storage information, and available payment options are provided below.
Each vial contains a labeled strength of 50 mg of Epitalon.
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
A published lab report from March 2024 provides measured results for the identified batch.
| Product name | Epitalon 50 mg |
|---|---|
| Active substance | Ephitalon Acetate |
| Labeled strength | 50 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 50 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
The latest published report for batch #HDEPT23, dated March 22, 2024, measured 54.46 mg against the stated 50 mg labeled strength.
Open the Lab Reports tab to view the full report and check the batch number associated with the test.
Other peptide options from the same product line include AOD-9604 5 mg, a peptide fragment investigated for metabolic research, and SS-31 50 mg, a mitochondrial-targeted peptide. These products differ in their peptide structure and the research applications for which they are used.
Published Test Result
A published lab report for Dragon Pharma Epitalon 50 mg is provided below with the test date, measured result and reported batch number. The result can be compared directly with the product's labeled strength of 50 mg.
Science & Research
Epitalon (also referred to as Ephitalon Acetate) is a synthetic tetrapeptide that has been investigated in preclinical research for its potential effects on cellular aging and related physiological processes. This section provides a brief overview of what is known about this peptide from research literature.
Epitalon is a synthetic peptide composed of four amino acids. Its structure is designed to mimic certain naturally occurring regulatory peptides involved in cellular processes.
Preclinical research has investigated Epitalon for its potential effects on cellular aging, telomere length regulation, and other physiological processes. The peptide has been studied in laboratory settings for its interactions with cellular pathways.
The precise mechanism of action of Epitalon is not fully characterized. It is believed to interact with specific cellular targets that may influence gene expression and other regulatory pathways, though the exact molecular mechanisms remain an area of ongoing investigation.
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Peer-reviewed research on Epitalon is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
Peptide research compounds such as Epitalon have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
Epitalon has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
The full range of cellular effects of Epitalon, including its potential influence on gene expression and telomere regulation, is not fully characterized in a clinical context.
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
The potential interactions between Epitalon and other hormonal or physiological systems are not fully understood and have not been characterized in clinical research.
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
The long-term effects and safety profile of Epitalon have not been established in any population. Research on this peptide is still in the early stages.
Medical advice is particularly important for individuals with cancer or a history of cancer, autoimmune conditions, cardiovascular disease, or those taking medications that affect cellular proliferation or gene expression. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Common Product Questions
Quick answers about Epitalon 50 mg specifications, the published lab report, storage, shipping, Bitcoin payment and general product information.
Dragon Pharma Epitalon 50 mg is a lyophilized peptide product containing 50 mg of Ephitalon Acetate per vial. It is supplied in a 2 mL vial for research purposes.
The active substance is Ephitalon Acetate, a synthetic tetrapeptide that has been investigated in preclinical research for its potential effects on cellular aging and related physiological processes.
Each vial contains a labeled strength of 50 mg of Epitalon.
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
The published lab report dated March 22, 2024 for batch #HDEPT23 measured 54.46 mg against the stated 50 mg labeled strength.
No. Each report applies to the sample submitted for that specific test and the batch identified in the report. It does not independently verify the content or condition of every individual vial.
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Epitalon 50 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Epitalon is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
Please log in to write Epitalon 50 mg review.
Trade Name: Melanotan 2
Compound: Melanotan 2
Strength: 10 mg/vial
Container: 2 mL Vial
Manufacturer: Dragon Pharma
Lab Tested: View Result
Trade Name: Ipamorelin
Compound: Ipamorelin
Strength: 5 mg/vial
Container: 2 mL Vial
Manufacturer: Dragon Pharma
Lab Tested: View Result